Versor Investments LP Ocular Therapeutix, Inc Transaction History

Versor Investments LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$3.01 - $5.22 $58,092 - $100,746	19,300 Added 136.88%	33,400 $134,000
Q1 2022 May 04, 2022	SELL	$4.83 - $7.35 $74,382 - $113,190	-15,400 Reduced 52.2%	14,100 $70,000
Q4 2021 Feb 08, 2022	BUY	$6.16 - $12.07 $118,272 - $231,744	19,200 Added 186.41%	29,500 $206,000
Q3 2021 Nov 04, 2021	BUY	$9.7 - $14.34 $99,909 - $147,702	10,300 New	10,300 $103,000

173

136M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $620M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.